Ngā hua rapu - Prashant Kumar Pandey
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
-
2
HER-2 Receptor and αvβ3 Integrin Dual-Ligand Surface-Functionalized Liposome for Metastatic Breast Cancer Therapy mā Dilip Kumar Arya, Hemali Deshpande, Ashish Kumar, Kumarappan Chidambaram, Prashant Kumar Pandey, Shabnam Anjum, Payal Deepak, Vikas Kumar, Santosh Kumar, Giriraj Pandey, Saurabh Srivastava, Paruvathanahalli Siddalingam Rajinikanth
I whakaputaina 2024Artigo -
3
BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth mā Srinivas Reddy Boreddy, Reshmi Nair, Prashant Kumar Pandey, Anshu Kuriakose, Shivakumar Bhadravathi Marigowda, Chaitali Dey, Arindam Banerjee, Hanumant Kulkarni, Milind Sagar, Shiv Ram Krishn, Shruthi Rao, Madhukara AR, Vinita Tiwari, Bhavna Alke, Prashantha Kumar MV, Meena Shri, Chaitrali Dhamne, Sonal Patel, Pinky Sharma, Sankar Periyasamy, Jaya Bhatnagar, Moni Abraham Kuriakose, Ram Bhupal Reddy, Amritha Suresh, Suma Sreenivas, Nagaraja Govindappa, Praveen Reddy Moole, Usha Bughani, Seng-Lai Tan, Pradip Nair
I whakaputaina 2023Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Cancer
Cancer research
Chemistry
2019-20 coronavirus outbreak
Antibody
Artificial intelligence
Betacoronavirus
Biochemistry
Breast cancer
Carcinogenesis
Cetuximab
Computer science
Coronavirus disease 2019 (COVID-19)
Disease
Family medicine
Immunology
In vitro
Infectious disease (medical specialty)
Intensive care medicine
Liposome
Monoclonal antibody
Observational study
Oncology
Outbreak
Pandemic
Perspective (graphical)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology